The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. RPG Life Sciences's Dividend Payout Ratio for the
months ended in Mar. 2026 was 0.00.
The historical rank and industry rank for RPG Life Sciences's Dividend Payout Ratio or its related term are showing as below:
NSE:RPGLIFE'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.23 Med: 0.28 Max: 0.37
Current: 0.29
During the past 13 years, the highest Dividend Payout Ratio of RPG Life Sciences was 0.37. The lowest was 0.23. And the median was 0.28.
NSE:RPGLIFE's Dividend Payout Ratio is ranked better than 63.06% of 444
companies
in the Drug Manufacturers industry
Industry Median: 0.38
vs NSE:RPGLIFE: 0.29
During the past 12 months, RPG Life Sciences's average Dividends Per Share Growth Rate was 25.00% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 27.70% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of RPG Life Sciences was 44.20% per year. The lowest was -12.60% per year. And the median was 14.50% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
RPG Life Sciences (NSE:RPGLIFE) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
RPG Life Sciences Dividend Payout Ratio Related Terms
RPG Life Sciences Dividend Payout Ratio Historical Data
* Premium members only.
The historical data trend for RPG Life Sciences's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:RPGLIFE vs ZTS, UTHR: Dividend Payout Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, RPG Life Sciences's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
RPG Life Sciences Dividend Payout Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, RPG Life Sciences's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where RPG Life Sciences's Dividend Payout Ratio falls into.
RPG Life Sciences Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
RPG Life Sciences's Dividend Payout Ratio for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RPG Life Sciences (NSE:RPGLIFE) has a Dividend Payout Ratio of 0.00 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on RPG Life Sciences and its competitors. Over the past decade, RPG Life Sciences' Dividend Payout Ratio has ranged from 0.23 to 0.37. According to the industry distribution chart, RPG Life Sciences ranks #164 out of 444 companies in the Drug Manufacturers industry, placing it in the top 36.9%.
Is RPG Life Sciences' Dividend Payout Ratio too high?
RPG Life Sciences' current Dividend Payout Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.23 to a high of 0.37. Based on the distribution chart, RPG Life Sciences ranks #164 out of 444 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, RPG Life Sciences has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does RPG Life Sciences' Dividend Payout Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, RPG Life Sciences ranks #164 out of 444 companies for Dividend Payout Ratio. This puts RPG Life Sciences in the upper half of its industry. The industry median Dividend Payout Ratio is 0.38. Historically, RPG Life Sciences' own Dividend Payout Ratio has ranged from 0.23 to 0.37 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 444 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on RPG Life Sciences and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. RPG Life Sciences's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RPG Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, RPG Life Sciences (NSE:RPGLIFE) is currently considered Fairly Valued. The stock's GF Value™ is ₹2,353.66, compared to a current price of ₹2,416.50 — trading 2.7% above its estimated fair value. The current Dividend Payout Ratio is 0.00. RPG Life Sciences' overall GF Score™ is 92/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For RPG Life Sciences (NSE:RPGLIFE), the current Dividend Payout Ratio is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is RPG Life Sciences (NSE:RPGLIFE) Overvalued in 2026?
Based on GuruFocus' analysis, RPG Life Sciences stock appears to be overvalued.
The current stock price of ₹2,416.50 is trading 2.7% above its estimated GF Value™ of ₹2,353.66.
GuruFocus considers RPG Life Sciences to be Fairly Valued.
Key valuation signals for NSE:RPGLIFE:
Dividend Payout Ratio: 0.00
GF Value™: ₹2,353.66 vs. price of ₹2,416.50 (2.7% above fair value)
No single metric tells the full story. See the NSE:RPGLIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
RPG Life Sciences Ltd is an integrated pharmaceutical company. Its only reportable segment is the manufacturing and marketing of pharmaceutical products. Geographically, it derives a majority of revenue from India. The company operates across Domestic Formulations, International Formulations and Active Pharmaceutical Ingredients (API). It focuses on Nephrology, Oncology, Urology, Respiratory, Gastrointestinal, Cardiovascular, Gynaecology and Pediatrics, Vitamins and Minerals, Pain Management, Neurology, Anti-Dengue, Anti-Diabetic, and Derma.
92GF Score
Get the complete analysis for NSE:RPGLIFE
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:RPGLIFE has been successfully added to your 
